Rhode Island ranked 36th in the U.S. for venture capital investment of $2.1 million and 26th for five deals in the second quarter, according to The MoneyTree Report from PriceWaterhouseCoopers LLP and the National Venture Capital Association released Friday.
(Updated, 6:15 p.m.)
Ventas Inc., a real estate investment trust with more than 1,300 properties, has announced its intention to purchase substantially all of the assets of Wexford Science & Technology LLC.
(Updated 3:17 p.m.)
CVS Pharmacy Inc. will pay $3.5 million to settle allegations that 50 of its Massachusetts stores violated the Controlled Substances Act by filling forged prescriptions for addictive painkillers and other controlled substances more than 500 times between 2011 and 2014.